valeramide,
Pentanamide,
Valeramide,
626-97-1,
N-VALERAMIDE,
Pentanimidic acid,
UNII-TKL9TN43QK,
TKL9TN43QK,
IPWFJLQDVFKJDU-UHFFFAOYSA-N,
Valeramide, 97%,
MFCD00041895,
Valeric acid amide,
EINECS 210-974-0,
NSC 400223,
AI3-24387,
Pentanamide (Valeramide),
AC1L1ZAF,
AC1Q2VAJ,
SCHEMBL20284,
KSC353I5P,
ACMC-209n74,
DTXSID3060827,
CHEBI:16459,
CTK2F3457,
IPWFJLQDVFKJDU-UHFFFAOYSA-,
ZINC1529296,
7330AF,
ANW-34334,
LMFA08010002,
NSC400223,
SBB028169,
STL283920,
AKOS009031546,
FR-0155,
FS-4458,
MCULE-6419483436,
NE22996,
NSC-400223,
RTR-021562,
KS-000001Y3,
AN-46876,
CJ-05173,
CJ-23875,
SC-76721,
DB-054247,
TL8004238,
TR-021562,
Valeramide, pharmaceutical impurity standard,
FT-0603495,
ST51047125,
V0002,
EN300-19981,
C01842,
151116-EP2289887A2,
151116-EP2289888A2,
A833929,
I05-0339,
Z282264782,
InChI=1/C5H11NO/c1-2-3-4-5(6)7/h2-4H2,1H3,(H2,6,7),
palmitic acid,
Unknown Ligand,
MYRISTIC ACID,
C5H11NO,
C5-H11-N-O,
CID12298,
MYR,
PLM,
UNL,